Cite
Prognostic Significance Of Pre-Treatment Neutrophil-To-Lymphocyte Ratio In Patients with Oropharyngeal Cancer Treated with Radiotherapy
MLA
Amit Jethanandani, et al. “Prognostic Significance Of Pre-Treatment Neutrophil-To-Lymphocyte Ratio In Patients with Oropharyngeal Cancer Treated with Radiotherapy.” International Journal of Radiation Oncology*Biology*Physics, vol. 105, Sept. 2019, pp. E426–27. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........2383f2e75b3a5fcca49ff2e00cf4245e&authtype=sso&custid=ns315887.
APA
Amit Jethanandani, David I. Rosenthal, Courtney Pollard, Erich M. Sturgis, Faye M. Johnson, Baher Elgohari, Jay Reddy, Jack Phan, Houda Bahig, C.D. Fuller, William H. Morrison, Gary Brandon Gunn, S.J. Frank, Sweet Ping Ng, & Adam S. Garden. (2019). Prognostic Significance Of Pre-Treatment Neutrophil-To-Lymphocyte Ratio In Patients with Oropharyngeal Cancer Treated with Radiotherapy. International Journal of Radiation Oncology*Biology*Physics, 105, E426–E427.
Chicago
Amit Jethanandani, David I. Rosenthal, Courtney Pollard, Erich M. Sturgis, Faye M. Johnson, Baher Elgohari, Jay Reddy, et al. 2019. “Prognostic Significance Of Pre-Treatment Neutrophil-To-Lymphocyte Ratio In Patients with Oropharyngeal Cancer Treated with Radiotherapy.” International Journal of Radiation Oncology*Biology*Physics 105 (September): E426–27. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........2383f2e75b3a5fcca49ff2e00cf4245e&authtype=sso&custid=ns315887.